|
We hope you have found this website helpful and would welcome any feedback, comments or suggestions you might have. Send Feedback. |
Recovery [62]
Relapse Prevention |
|
|
|
|
|
Assess need for psychological intervention
|
|
Assess need for pharmacological intervention and have full discussion about preferences
of service user |
|
Discuss with service user continuing antipsychotic for 1 - 2 years |
|
|
|
|
|
|
|
|
|
Especially if:
- At risk of relapse.
- Recent Relapse.
- Persistent symptoms
|
|
Especially if:
- Persistent symptoms.
- Lack of insight.
- Poor treatment
adherence
|
|
Oral Antipsychotic |
|
Depots if:
- Service user prefers, or
- Avoidance of covert non-adherence is a clinical priority
|
|
|
|
|
|
|
|
|
|
Family Intervention
|
|
CBT
|
|
- Continue dosage regimens
- Standard doses
- One antipsychotic only
|
|
- Use test dose according to BNF
- Use within standard dosage and interval ranges
|
|
|
|
|
|
|
|
|
|
More than 6 month course of treatment with more than 10 sessions |
|
|
|
|
|
Consider service user preference for:
- Mode of administration
- Organisation of administration (where and from whom)
|
Monitor Clinical Response and side effects
|
|
Clinical Response
|
|
-
ESP/akathisia,
-
Weight gain/diabetes,
-
Sexual Dysfunction,
-
Lethargy,
-
Effects
on eyes
|
|
|
|
Assess for work, education and other occupational Activities
|
|
Help individuals find employment and/or physical and social activities |
|
|
|
|
|
|
|
|
Side Effects
|
|
|
|
|
|
|
|
|
Consider community resources for service users and carers |
|
|
|
|
|
|
|
If individual remains ill or has persisting symptoms |
|
Consider treatment resistance |
|
|
|